A hospital discharge is not the end of a patient's journey, but the start of a frantic, paper-heavy scramble for a post-acute care bed. For admissions teams at skilled nursing facilities and home health agencies, that scramble is a daily reality of faxed referrals, phone tag, and manual eligibility checks. Magicare AI, a New York-based startup that recently emerged from stealth with a $3.6 million pre-seed round, is betting that this specific bottleneck is the right place to insert an AI layer [Access Newswire]. Its pitch is not another broad clinical decision tool, but an 'agentic operating system' designed to triage and orchestrate the flow of patients from hospital to post-acute care [intro.magicare.ai]. The company, formerly known as Exponential Triage, is targeting a corner of healthcare where operational friction directly impacts both business viability and, ultimately, patient placement [Health Care Association of New Jersey].
The Wedge in Post-Acute Admissions
The company's focus is deliberately narrow. Rather than building for the acute hospital setting or a payer's back office, Magicare is starting with the admissions teams at post-acute care providers. Its software ingests referrals and discharge information, using AI to triage them for urgency, payer compatibility, and bed availability [LinkedIn]. The goal is to automate the coordination steps that currently consume staff hours, aiming to fill beds faster and reduce administrative burden. By framing its product as an operating system, Magicare suggests a level of workflow orchestration that could eventually integrate with electronic health records and referral platforms, though such integrations are not detailed in its early materials. The initial commercial product is centered on reinventing this admissions process, a high-volume, high-stakes workflow where minutes can determine whether a patient gets a bed [Access Newswire].
From Hedge Fund to Healthcare
The founding team brings an outsider's perspective to a traditionally insular sector. CEO Daniel Schoenbrun, the solo founder, spent approximately 15 years in quantitative roles at blue-chip multi-manager hedge funds before pivoting to healthtech [LinkedIn, 2026]. His background in decision science, honed at the University of Pennsylvania's Wharton School, informs the company's data-driven approach to referral triage [rocketreach.co, 2026]. He is joined by a small, early-stage team that includes Chief Revenue Officer Chen Yakar and Head of Customer Success Shmuel 'Sam' Eisenberg, who held the same role at the company's prior incarnation, Exponential Care [LinkedIn, 2026] [growthmentor.com, 2026]. The $3.6 million pre-seed was led by Mana Ventures, a vote of confidence in a founder making a sharp career turn into the heavily regulated healthcare space [FinSMEs, April 2026].
| Role | Name | Background Note |
|---|---|---|
| Founder & CEO | Daniel Schoenbrun | Formerly at multi-manager hedge funds; BS in Economics, Decision Science from Wharton. |
| CRO | Chen Yakar | Leads revenue and sales. |
| Head of CS | Shmuel 'Sam' Eisenberg | Previously Head of CS at Exponential Care (former company name). |
| Director of Growth | Isaac Stark | Focus on sales and growth for the former Exponential Triage. |
The Risks of an Unproven Playbook
Magicare's bet is compelling but faces significant headwinds. The post-acute care market is fragmented, with thousands of independent facilities often using legacy systems. Selling into this environment requires a deep understanding of local referral networks and payer contracts, a sales motion that is notoriously relationship-driven. Furthermore, while the company's AI claims focus on operational efficiency, any tool touching patient flow enters a realm of clinical responsibility and data privacy. The company has not yet indicated it is pursuing FDA clearance for its software, which may limit its claims to non-clinical workflow support. The competitive landscape, while not naming direct rivals, is crowded with larger EHR vendors and niche post-acute software providers that could easily build or buy similar functionality.
- Sales complexity. The target customer base is geographically dispersed and operationally diverse, making a scalable go-to-market motion difficult to engineer from scratch.
- Integration depth. The promise of an 'operating system' implies deep, bidirectional data exchange with hospital EHRs and post-acute software, a technical and commercial hurdle that has sunk many healthtech startups.
- Regulatory posture. Operating in the patient referral stream without clear regulatory boundaries could attract scrutiny, especially if AI-driven triage suggestions are perceived as influencing care decisions.
The company's rebuttal likely hinges on its narrow focus. By not trying to be everything to everyone, it can embed itself as a specialist tool for admissions directors, a role with clear pain points and budget authority. The pre-seed capital provides runway to prove that this wedge can create a durable beachhead.
What to Watch in the Next Twelve Months
The coming year will be about moving from concept to concrete traction. Key milestones will include naming its first publicly referenceable health system or large post-acute network customer, detailing the specifics of its AI models and their validation, and potentially announcing a seed round to scale its commercial team. The hiring of a CRO so early suggests a focus on commercialization, but the real test will be whether facilities see enough value in faster bed turns to adopt a new, standalone platform. For Magicare, the path forward is to demonstrate that its software doesn't just add another dashboard, but actually changes the economics of admissions for its clients.
The patient population here is often elderly, frail, and medically complex, transitioning from a hospital stay to a skilled nursing facility or home health service. The standard of care today for that transition is a chaotic, manual process reliant on fax machines, spreadsheets, and phone calls, where communication breakdowns can lead to delays in care, missed medications, and patient anxiety. If Magicare's operating system works, it won't just be about filling beds faster. It could mean a smoother, safer handoff for a vulnerable population at a critical moment in their recovery.
Sources
- [Access Newswire] Magicare Exits Stealth with $3.6M Pre-Seed to Build the Agentic Operating System for Post‑Acute Care | https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/magicare-exits-stealth-with-3.6m-pre-seed-to-build-the-agentic-operat-1160959
- [intro.magicare.ai] Magicare AI introductory site | https://intro.magicare.ai/
- [Health Care Association of New Jersey] Exponential Triage - Health Care Association of New Jersey | https://www.hcanj.org/associate-members/exponential-triage/
- [LinkedIn] Magicare AI (formerly Exponential Triage) company profile | https://www.linkedin.com/company/magicareai
- [FinSMEs, April 2026] Magicare Raises $3.6M Pre-Seed in Funding | https://www.finsmes.com/2026/04/magicare-raises-3-6m-pre-seed-in-funding.html
- [LinkedIn, 2026] Daniel Schoenbrun profile | https://www.linkedin.com/in/daniel-schoenbrun/
- [rocketreach.co, 2026] Daniel Schoenbrun Email & Phone Number | Exponential CEO Contact Information | https://rocketreach.co/daniel-schoenbrun-email_845812640
- [growthmentor.com, 2026] Sam Eisenberg - Co-Founder @ Design For Decks, Head of CS @ Exponential Care | https://app.growthmentor.com/mentors/sam-eisenberg